Europlasma [ALEUP] vs Aurea [AURE] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Europlasma wins in 5 metrics, Aurea Inc. wins in 9 metrics, with 1 ties. Aurea Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Europlasma | Aurea Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.00 | 50.18 | Tie |
| Price-to-Book Ratio | N/A | 0.76 | N/A |
| Debt-to-Equity Ratio | -1.55 | 59.18 | Aurea Inc. |
| PEG Ratio | N/A | 20.55 | N/A |
| EV/EBITDA | -0.30 | 7.01 | Aurea Inc. |
| Profit Margin (TTM) | -73.96% | -0.77% | Aurea Inc. |
| Operating Margin (TTM) | -38.23% | -0.63% | Aurea Inc. |
| Return on Equity | 137.19% | -2.93% | Europlasma |
| Return on Assets (TTM) | -22.66% | 0.27% | Aurea Inc. |
| Free Cash Flow (TTM) | $-12.40M | $6.84M | Aurea Inc. |
| Dividend Yield | N/A | 2.48% | N/A |
| 1-Year Return | -50.00% | 7.41% | Aurea Inc. |
| Price-to-Sales Ratio (TTM) | 0.03 | 0.25 | Europlasma |
| Enterprise Value | $4.88M | $70.98M | Aurea Inc. |
| EV/Revenue Ratio | 0.08 | 0.32 | Europlasma |
| Revenue per Share (TTM) | $433 | $24 | Europlasma |
| Earnings per Share (Diluted) | $-88.61 | $-0.22 | Aurea Inc. |
| Beta (Stock Volatility) | -77.49 | 0.49 | Europlasma |
Europlasma vs Aurea Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Europlasma | -6.25% | 0.00% | -66.67% | -66.67% | -96.97% | -95.45% |
| Aurea Inc. | 0.00% | -2.05% | 3.61% | -2.05% | -5.59% | 1.41% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Europlasma | -50.00% | -50.00% | -50.00% | -50.00% | -50.00% | -50.00% |
| Aurea Inc. | 7.41% | -12.12% | -21.62% | 7.01% | 12.40% | 12.40% |
Performance & Financial Health Analysis: Europlasma vs Aurea Inc.
| Metric | ALEUP | AURE |
|---|---|---|
| Market Information | ||
| Market Cap | €1.64M | €55.70M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 71,307,339 | 464 |
| 90 Day Avg. Volume | 38,487,754 | 672 |
| Last Close | €0.00 | €5.74 |
| 52 Week Range | €0.00 - €22.00 | €5.24 - €6.78 |
| % from 52W High | -99.99% | -15.34% |
| All-Time High | €1.92 (Oct 07, 2025) | €13.40 (Mar 07, 2022) |
| % from All-Time High | N/A | -57.16% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.11% | -0.18% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.74% | -0.01% |
| Operating Margin (TTM) | -0.38% | -0.01% |
| Return on Equity (TTM) | 1.37% | -0.03% |
| Debt to Equity (MRQ) | -1.55 | 59.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-33.86 | €7.81 |
| Cash per Share (MRQ) | €18.79 | €2.93 |
| Operating Cash Flow (TTM) | €-22,600,000 | €13.73M |
| Levered Free Cash Flow (TTM) | €-2,054,250 | €27.08M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.48% |
| Last 12-Month Dividend | N/A | €0.15 |
Valuation & Enterprise Metrics Analysis: Europlasma vs Aurea Inc.
| Metric | ALEUP (Apr 26, 2026) | AURE (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.00 | 50.18 |
| Forward P/E | N/A | 20.55 |
| PEG Ratio | N/A | 20.55 |
| Price to Sales (TTM) | 0.03 | 0.25 |
| Price to Book (MRQ) | N/A | 0.76 |
| Market Capitalization | ||
| Market Capitalization | €1.64M | €55.70M |
| Enterprise Value | €4.88M | €70.98M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.08 | 0.32 |
| Enterprise to EBITDA | -0.30 | 7.01 |
| Risk & Other Metrics | ||
| Beta | -77.49 | 0.49 |
| Book Value per Share (MRQ) | €-33.86 | €7.81 |
Financial Statements Comparison: Europlasma vs Aurea Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ALEUP (2024) | AURE (2024) |
|---|---|---|
| Revenue/Sales | 42.45M | 244.88M |
| Cost of Goods Sold | 19.82M | 193.96M |
| COGS % of Revenue | 46.7% | 79.2% |
| Gross Profit | 22.63M | 50.92M |
| Gross Margin | 53.3% | 20.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -26.11M | 4.43M |
| Operating Margin | -61.5% | 1.8% |
| EBITDA | -6.53M | 17.39M |
| EBITDA Margin | -15.4% | 7.1% |
| Pre-Tax Income | -18.66M | 2.81M |
| Pre-Tax Income % of Revenue | -44.0% | 1.1% |
| Income Tax | -2.75M | 1.75M |
| Income Tax % of Revenue | -6.5% | 0.7% |
| Net Income (Profit) | -15.91M | 1.06M |
| Profit Margin | -37.5% | 0.4% |
Balance Sheet & Liquidity Metrics
| Metric | ALEUP (2024) | AURE (2024) |
|---|---|---|
| Cash & Equivalents | 1.74M | 30.84M |
| Total Current Assets | 38.66M | 113.89M |
| Total Current Assets % of Revenue | 91.1% | 46.5% |
| Total Current Liabilities | 50.30M | 85.05M |
| Total Current Liabilities % of Revenue | 118.5% | 34.7% |
| Long-Term Debt | 10.18M | 36.18M |
| Long-Term Debt % of Revenue | 24.0% | 14.8% |
| Total Shareholders Equity | -11.15M | 73.88M |
| Retained Earnings | -15.29M | 56.37M |
| Retained Earnings % of Revenue | -36.0% | 23.0% |
| Property, Plant & Equipment | 53.24M | 34.60M |
Cash Flow Statement Comparison
| Metric | ALEUP (2024) | AURE (2024) |
|---|---|---|
| Operating Cash Flow | -23.35M | 3.24M |
| Operating Cash Flow % of Revenue | -55.0% | 1.3% |
| Capital Expenditures | -1.52M | -8.54M |
| Free Cash Flow | -12.40M | 6.84M |
| FCF Margin | -29.2% | 2.8% |
| Debt Repayment | -1.71M | -26.65M |
| Common Stock Repurchase | -8,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALEUP | AURE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 52.64M | 9.35M |
| Float Shares | N/A | 1.50M |
| % Held by Insiders | N/A | 76.67% |
| % Held by Institutions | N/A | 8.90% |
| % Held by Public | N/A | 14.43% |
Dividend Analysis & Yield Comparison: Europlasma vs Aurea Inc.
| Metric | ALEUP | AURE |
|---|---|---|
| Last 12-Month Dividend | N/A | €0.15 |
| Last 12-Month Dividend Yield | N/A | 2.48% |
| 3-Year Avg Annual Dividend | N/A | €0.05 |
| 3-Year Avg Dividend Yield | N/A | 2.63% |
| 3-Year Total Dividends | N/A | €0.15 |
| Ex-Dividend Date | N/A | Nov 04, 2025 |